CybeRelease: (OTC PK: APPI) Announces Completion of Acquisition of Biodiesel Producer World Health Energy, Inc.

(CybeRelease, February 9, 2007) - Lake Harmony, PA - Advanced Plant Pharmaceuticals, Inc. (OTC BB: APPI) announced the closing of its acquisition of World Health Energy, Inc., an emerging energy company focused on biofuels and renewable energy production and distribution. A Current Report on Form 8-K containing details of this transaction will be filed with the Securities and Exchange Commission on or before February 13, 2007.

APPI’s board of directors has adopted a resolution to change its corporate name to World Health Energy, Inc., to reflect the acquisition of World Health Energy, Inc. and the new business plan to focus on biofuels and renewable energy production and distribution. APPI anticipates the name change will be completed within thirty days. A new ticker symbol to reflect the corporate name of World Health Energy, Inc. will be issued after the name change has been effected.

World Health Energy, Inc. plans to use renewable, cost-effective agricultural products domestically and around the world to develop natural alternative fuels. World Health Energy’s proposed biodiesel production plants are expected to be designed to produce biodiesel that complies to or exceeds international biodiesel production requirements and standards, including the European standard for Biodiesel EN 14214 as well as ASTM D6751 specifications.

The company plans on utilizing ultrasonic processing to produce its biodiesel, which the company’s management believes is more effective (than the conventional batch reactor process). This ultrasonic process can produce biodiesel (with yield in excess of 99%) in under 5 minutes as compared to the conventional batch reactor process which can require an hour or more. The company believes that the higher yielding process should provide the company with production cost advantages.

To be added to Advanced Plant Pharmaceutical’s corporate e-mail list for shareholders and interested investors, please send an e-mail to ir@advancedplantpharm.com.

To read the complete release, go to http://biz.yahoo.com/iw/070209/0213616.html

For a Free News letter, go to http://www.OTCReporter.com

CybeRelease Gainers are Digital River, Inc. (Nasdaq: DRIV), Open Text Corporation (Nasdaq: OTEX), Cell Genesys, Inc. (Nasdaq: CEGE), Take-Two Interactive Software, Inc. (Nasdaq: TTWO), CV Therapeutics, Inc. (Nasdaq: CVTX), Research Frontiers Incorporated (Nasdaq: REFR), Mikron Infrared, Inc. (Nasdaq: MIKR) and Liquidity Services, Inc. (Nasdaq: LQDT).

CybeRelease Decliners are Silicon Image, Inc. (Nasdaq: SIMG), Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), XOMA Ltd. (Nasdaq: XOMA), Wynn Resorts, Limited (Nasdaq: WYNN), MRV Communications, Inc. (Nasdaq: MRVC), United Online, Inc. (Nasdaq: UNTD), Fieldstone Investment Corporation (Nasdaq: FICC) and Altair Nanotechnologies Inc. (Nasdaq: ALTI).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for informational purposes only and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.

Contact Information

C. P. Barry

Media Contact

CybeRelease.com

Contact via E-mail